CStone Presented Preclinical Data for Three Novel or Differentiated ADCs at AACR 2026, Including CS5007 (EGFR/HER3)
Summary
SUZHOU, China, April 20, 2026 /PRNewswire/ -- CStone Pharmaceuticals ('CStone,' HKEX: 2616), an innovation-driven biopharmaceutical company focused on the resea...
Description
SUZHOU, China, April 20, 2026 /PRNewswire/ -- CStone Pharmaceuticals ('CStone,' HKEX: 2616), an innovation-driven biopharmaceutical company focused on the resea...
Original reporting
AFBytes is a read-only aggregator. Use the original source for full context and complete reporting.
Open original source